The role of brain natriuretic peptide in population screening.
While measurement of plasma BNP concentration has been shown to be useful in the diagnosis of heart failure, its role as a screening test for detection of pre-clinical ventricular remodeling or dysfunction in the general population has not been established. Here we review available population-based studies assessing the predictive characteristics of BNP for the detection of pre-clinical structural heart disease (Stage B Heart Failure).
Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Liselotte N
LN
Dyrbye
Margaret M
MM
Redfield
D001681:Biological Assay; D018450:Disease Progression; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D008403:Mass Screening; D020097:Natriuretic Peptide, Brain / Q000032:analysis* / Q000097:blood; D020257:Ventricular Remodeling / Q000502:physiology
D020097:Natriuretic Peptide, Brain